News

Press Releases
In Russia, the vaccine TRIVAID against measles, mumps, and rubella has been registered, with an experience of more than 300 million doses administered worldwide.
image/svg+xml May 21, 2024
Learn more
RT
In Russia, trials have begun for a meningococcal vaccine against five virus strains.
image/svg+xml Feb. 22, 2023
Learn more
РИА Новости
Experts Highlight the Main Issue Facing the Russian Pharmaceutical Market in 2023
image/svg+xml Dec. 28, 2022
Learn more
Газета.Ру
Pharm Aid Reveals Workforce Plans for Vaccine Production Plant Near Kaluga
image/svg+xml Dec. 26, 2022
Learn more
Газета.Ру
Pharm Aid CEO Metov Discusses the Drugs Russia Needs to Substitute with Domestic Production
image/svg+xml Dec. 26, 2022
Learn more
VADEMECUM
Azamat Metov: "Our Case is About How Things Can Be Non-linear"
image/svg+xml Nov. 9, 2022
Learn more

The company has established a pharmacovigilance system in accordance with Russian and international requirements.

If you become aware of an adverse reaction associated with the use of our product, please report it to us by any convenient means.

  • Fill out the feedback form on our website
  • By calling the toll-free hotline +7 (800) 350-80-24
  • By email pv@pharmaid.com

By entering your contact details and clicking the 'send' button, you confirm your consent to the processing of your personal data, in accordance with Federal Law No. 152-FZ of July 27, 2006 'On Personal Data,' under the conditions and for the purposes specified in the Consent for Personal Data Processing.